GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Firebrick Pharma Ltd (ASX:FRE) » Definitions » Quick Ratio

Firebrick Pharma (ASX:FRE) Quick Ratio : 6.36 (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Firebrick Pharma Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Firebrick Pharma's quick ratio for the quarter that ended in Jun. 2024 was 6.36.

Firebrick Pharma has a quick ratio of 6.36. It generally indicates good short-term financial strength.

The historical rank and industry rank for Firebrick Pharma's Quick Ratio or its related term are showing as below:

ASX:FRE' s Quick Ratio Range Over the Past 10 Years
Min: 5.12   Med: 12.44   Max: 54.31
Current: 6.36

During the past 4 years, Firebrick Pharma's highest Quick Ratio was 54.31. The lowest was 5.12. And the median was 12.44.

ASX:FRE's Quick Ratio is ranked better than
91.4% of 1035 companies
in the Drug Manufacturers industry
Industry Median: 1.4 vs ASX:FRE: 6.36

Firebrick Pharma Quick Ratio Historical Data

The historical data trend for Firebrick Pharma's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Firebrick Pharma Quick Ratio Chart

Firebrick Pharma Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Quick Ratio
54.31 18.51 5.12 6.36

Firebrick Pharma Semi-Annual Data
Jun22 Dec22 Jun23 Dec23 Jun24
Quick Ratio 18.51 10.50 5.12 4.37 6.36

Competitive Comparison of Firebrick Pharma's Quick Ratio

For the Drug Manufacturers - General subindustry, Firebrick Pharma's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Firebrick Pharma's Quick Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Firebrick Pharma's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Firebrick Pharma's Quick Ratio falls into.



Firebrick Pharma Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Firebrick Pharma's Quick Ratio for the fiscal year that ended in Jun. 2024 is calculated as

Quick Ratio (A: Jun. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(2.092-0.24)/0.291
=6.36

Firebrick Pharma's Quick Ratio for the quarter that ended in Jun. 2024 is calculated as

Quick Ratio (Q: Jun. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(2.092-0.24)/0.291
=6.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Firebrick Pharma  (ASX:FRE) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Firebrick Pharma Quick Ratio Related Terms

Thank you for viewing the detailed overview of Firebrick Pharma's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Firebrick Pharma Business Description

Traded in Other Exchanges
N/A
Address
440 Collins Street, Level 10, Melbourne, VIC, AUS, 3000
Firebrick Pharma Ltd is an Australian pharmaceutical developer. It is engaged in the development and commercialization of povidone-iodine (PVP-I) products under the Nasodine brand. Its Nasodine Nasal Spray which is in the commercialization phase, is a broad-spectrum anti-viral spray, designed to be an effective treatment and prevention of respiratory viral infections such as the common cold. In parallel, the company is also engaged in the development of the follow-on Nasodine brand products.

Firebrick Pharma Headlines

No Headlines